ChargePointTechnology, a Speke, Liverpool, UK-based manufacturer which supplies precision containment valves to large pharmaceutical and chemicals businesses, received a £1.625m in financing.
The deal includes an investment by The North West Fund for Mezzanine, which provided £900k and an injection of £725k from Enterprise Ventures via the Coalfields Funds.
The company intends to use the funds to recruit additional skilled staff (over 15 new jobs expected) and develop new high tech products for export.
Led by Chris Eccles, Managing Director, ChargePoint is a manufacturer of precision valve which provide an accurate means of transferring powders from one vessel to another during the production process.
Originally developed in 1996 in conjunction with GlaxoSmithKline, ChargePoint valves are now used by major pharmaceutical manufacturers globally and increasingly in other industries such as chemical, bio-pharmaceutical, food manufacture and consumer goods.
Customers include GSK, Pfizer, Henkel,DuPont, INEOS, Johnson & Johnson, Eli Lilly and Sanofi Aventis.
The company currently employs 45 staff at its manufacturing facility in Speke.